Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Elagolix

Elagolix

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Elagolix

18 trials tracked of Elagolix: 10 in phase 3 or 4 and 1 with published results. The most-cited published study has 3 citations.

18Trials tracked
10Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Phase 3 9 Phase 2 8
  1. Phase 4 A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women Completed · 3 cited
  2. Phase 3 Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women Completed
  3. Phase 3 An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids Completed
  4. Phase 3 Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study) Completed
  5. Phase 3 A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain Completed
  6. Phase 3 A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain Completed
Show 12 more trials
  1. Phase 3 Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Adults With Moderate to Severe Endometriosis-Associated Pain Completed
  2. Phase 3 A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain Completed
  3. Phase 3 Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women Completed
  4. Phase 3 Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain Completed
  5. Phase 2 Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF) Completed
  6. Phase 2 Efficacy and Safety Study of Elagolix in Women With Endometriosis Completed
  7. Phase 2 Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome Completed
  8. Phase 2 Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids Completed
  9. Phase 2 Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in Endometriosis Completed
  10. Phase 2 An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With Endometriosis Completed
  11. Phase 2 Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of Endometriosis Completed
  12. Phase 2 Elagolix for Fertility Enhancement Clinical Trial Completed

Showing the 18 most-cited and recently-updated of 18 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.